IMI impact on diabetes - event

About this event

IMI has a strong diabetes project portfolio, covering T1,  T2 and diabetes complications, with several projects addressing different aspects of those diseases. Some are studying the underlying causes of the disease and the internal processes that lead to the destruction of the cells in the pancreas that produce insulin, in order to develop treatments. Others aim to detect clues as to how the disease will progress in different patients. Finally, many projects focus on detecting, preventing and treating the complications associated with diabetes.

This event was part of  a series of  live sessions that IMI is organising on IMI Impacts, where key actors explored the key challenges in their respective fields and demonstrate how IMI contributed. During these sessions, we also shared patients’ testimonies, as they are the ultimate beneficiaries of IMI’s funded research.

Furthermore, we engaged IMI stakeholders in a broader discussion on IMI’s impact. With this initiative, we demonstrated the successful IMI model of radical collaboration.

 

Agenda and presentations